Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immunovia Provides Update On COVID-19 Pandemic

May 13 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA PROVIDES THIRD UPDATE DURING COVID-19 PANDEMIC
    * DUE TO EXTENSION OF EMERGENCY ORDER, IMMUNOVIA'S LAB
LOCATED IN
MARLBOROUGH, MASSACHUSETTS WILL REMAIN CLOSED AT THIS TIME
    * IS NOW FORCED TO REVISE COMPANY'S TIMELINE AND SALES START
DATE
FOR IMMRAY™ PANCAN-D, NOW TARGETING Q4 2020
    * ONGOING VERIFICATION STUDY WILL BE COMPLETED IN Q3 2020
AND
VALIDATION STUDY WILL BE COMPLETED IN Q4 2020.

Source text for Eikon:  ID:nWkrvVGpB 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))

Recent news on Immunovia AB (publ)

See all news